- Home
- J&J Innovative Medicine
J&J Innovative Medicine
-
Johnson & Johnson named a 2019 Fortune World’s Most Admired Company
The company has been honored with a spot on the prestigious list for the 17th year in a row for its innovative spirit and commitment to social responsibility, among other respected attributes. -
What you need to know about Johnson & Johnson’s 2018 full-year earnings report
Check out this infographic breakdown of the company’s annual earnings report, with key performance highlights from its consumer, pharmaceutical and medical devices businesses over the last year. -
5 unique animal conservation programs aimed at helping fragile species
Pandas and owls and bats, oh my! We’re taking a look at a few of the ways Johnson & Johnson is working to help these and other imperiled species thrive—from the U.S. to the UK. -
“I have HIV": This researcher is fighting the disease—and the stigma attached to it
It’s been 30 years since the first World AIDS Day was recognized. Jens Van Roey, M.D., shares how a fateful diagnosis coincidentally that same year transformed him from a humble physician into a tireless champion for those afflicted with the disease. -
What you need to know about Johnson & Johnson’s 2018 third-quarter earnings
Learn how the company’s consumer, pharmaceutical and medical devices businesses performed in the third quarter of 2018 in this snapshot of its latest earnings report. -
The quest to end tuberculosis: 17 memorable moments in innovation
Johnson & Johnson has been instrumental in helping bring us closer to a TB-free world through its groundbreaking work with multidrug-resistant TB. -
Meet one of Johnson & Johnson’s very own pandas
He may not wear a lab coat, but Johnson & Johnson (that’s his name!) is a member of the family, thanks to a conservation partnership between Xian Janssen and the Shaanxi Academy of Forestry Qinling Mountains Giant Panda Breeding Center. We catch up with the mischievous youngster on the anniversary of his adoption ceremony.
-
Meet a Johnson & Johnson researcher poised to crack the HIV vaccine code
In the lead-up to the recent International AIDS Society Conference on HIV Science in the Netherlands, we sat down with Hanneke Schuitemaker, who’s hard at work on the holy grail of HIV research: a preventive treatment. -
What you need to know about Johnson & Johnson’s 2018 second-quarter earnings
In this recap of Johnson & Johnson’s latest earnings report, you can learn how the company’s consumer, pharmaceutical and medical devices businesses performed in the second quarter of 2018. -
“Johnson & Johnson helped me transition": Meet an employee who’s now living his true self.
For International Transgender Day of Visibility, Clark Musto shares his inspiring story—one made possible, in part, due to the support he received at work.